Decrease of a specific biomarker of collagen degradation in osteoarthritis, Coll2-1, by treatment with highly bioavailable curcumin during an exploratory clinical trial.
Henrotin, Yves
Decrease of a specific biomarker of collagen degradation in osteoarthritis, Coll2-1, by treatment with highly bioavailable curcumin during an exploratory clinical trial. [electronic resource] - BMC complementary and alternative medicine May 2014 - 159 p. digital
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
1472-6882
10.1186/1472-6882-14-159 doi
Aged
Anti-Inflammatory Agents--therapeutic use
Anti-Inflammatory Agents, Non-Steroidal--therapeutic use
Biomarkers--blood
C-Reactive Protein--metabolism
Collagen--blood
Collagen Type I--urine
Curcumin--therapeutic use
Extracellular Matrix Proteins--blood
Female
Humans
Male
Middle Aged
Osteoarthritis--drug therapy
Osteoarthritis, Knee--drug therapy
Pain Measurement
Peptides--urine
Peroxidase--blood
Phytotherapy
Treatment Outcome
Decrease of a specific biomarker of collagen degradation in osteoarthritis, Coll2-1, by treatment with highly bioavailable curcumin during an exploratory clinical trial. [electronic resource] - BMC complementary and alternative medicine May 2014 - 159 p. digital
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
1472-6882
10.1186/1472-6882-14-159 doi
Aged
Anti-Inflammatory Agents--therapeutic use
Anti-Inflammatory Agents, Non-Steroidal--therapeutic use
Biomarkers--blood
C-Reactive Protein--metabolism
Collagen--blood
Collagen Type I--urine
Curcumin--therapeutic use
Extracellular Matrix Proteins--blood
Female
Humans
Male
Middle Aged
Osteoarthritis--drug therapy
Osteoarthritis, Knee--drug therapy
Pain Measurement
Peptides--urine
Peroxidase--blood
Phytotherapy
Treatment Outcome